Data / Research funding / Massachusetts / Dynocardia, Inc.
Dynocardia, Inc.: 3 NIH awards ($5.1M) and 2 NSF awards ($1.3M), fiscal years 2021 to 2026
Dynocardia, Inc. in Lowell, MA is funded under 3 NIH awards ($5.1M) and 2 NSF awards ($1.3M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- HMN7FWLXJ1H4
- State
- Massachusetts
Awards
5 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| ViTrack: Wearable, accurate, continuous blood pressure monitor to improve outcomes in hypertensive diseases of pregnancy | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $2,425,925 | January 15, 2023 | December 31, 2024 | THANIKACHALAM, MOHAN | reporter.nih.gov |
| Continuous non-invasive assessment of blood pressure profile in persons with Alzheimer's and its related dementias | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,144,152 | June 15, 2021 | May 31, 2023 | THANIKACHALAM, MOHAN | reporter.nih.gov |
| SBIR Phase II: Development of motion artifact correction systems for ViTrack: an accurate, continuous, and non-invasive blood pressure monitor | NSF | Start-ups and Small Businesses Section | 2024 | $999,553 | September 15, 2024 | August 31, 2026 | Mohan Thanikachalam | nsf.gov |
| Design verification and validation of ViTrack - an accurate, continuous, non-invasive blood pressure monitor | NIH | National Heart, Lung, and Blood Institute | 2024 | $499,881 | September 1, 2024 | August 31, 2025 | THANIKACHALAM, MOHAN | reporter.nih.gov |
| SBIR Phase I: Motion artifact management for accurate and continuous non-invasive blood pressure monitoring | NSF | Translational Impacts | 2022 | $256,000 | March 1, 2022 | February 28, 2023 | Mohan Thanikachalam | nsf.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2024 | 2 | $1,657,443 | 1 | $999,553 |
| 2023 | 1 | $1,268,363 | 0 | $0 |
| 2022 | 1 | $1,170,297 | 1 | $256,000 |
| 2021 | 1 | $973,855 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Bioengineering
- Cardiovascular
- Hypertension
- Clinical Research
- Clinical Trials and Supportive Activities
- Prevention
- Acquired Cognitive Impairment
- Aging
- Alzheimer's Disease
- Alzheimer's Disease Related Dementias (ADRD)
- Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
- Behavioral and Social Science
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.